Zobrazeno 1 - 10
of 1 913
pro vyhledávání: '"Pierre I., Karakiewicz"'
Autor:
Fabian Falkenbach, Giovanni Mazzucato, Zhe Tian, Pierre I. Karakiewicz, Markus Graefen, Thomas Steuber, Derya Tilki, Daniel Koehler, Burkhard Beyer, Pierre Tennstedt, Sophie Knipper, Lars Budäus, Tobias Maurer
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 1-7 (2024)
Background and objective: In patients with oligorecurrent prostate cancer (PCa), prostate-specific membrane antigen–targeted radioguided surgery (PSMA-RGS) prolongs treatment-free survival. Data on patient-reported outcome measures (PROMs) are lack
Externí odkaz:
https://doaj.org/article/eae709c66f0d464ab1a9165bf132e840
Autor:
Pietro Scilipoti, Giuseppe Rosiello, Federico Belladelli, Marco Gambirasio, Francesco Trevisani, Arianna Bettiga, Chiara Re, Giacomo Musso, Francesco Cei, Lucia Salerno, Zhe Tian, Pierre I. Karakiewicz, Alexandre Mottrie, Isaline Rowe, Alberto Briganti, Roberto Bertini, Andrea Salonia, Francesco Montorsi, Alessandro Larcher, Umberto Capitanio
Publikováno v:
European Urology Open Science, Vol 69, Iss , Pp 73-79 (2024)
Background and objective: Metabolic syndrome (MetS) is a clinical condition associated with higher rates of overall and cardiovascular mortality. There is scarce evidence regarding the impact of MetS on surgical and functional outcomes for patients u
Externí odkaz:
https://doaj.org/article/87c3526ed5904a1b9f4186f24703b70c
Autor:
Francesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, Andrea Panunzio, Zhe Tian, Fred Saad, Marcus Graefen, Michele Gallucci, Alberto Briganti, Francesco Montorsi, Felix K.H. Chun, Shahrokh F. Shariat, Alessandro Antonelli, Giovanni Guano, Guglielmo Mantica, Marco Borghesi, Nazareno Suardi, Carlo Terrone, Pierre I. Karakiewicz
Publikováno v:
Current Urology, Vol 18, Iss 2, Pp 128-132 (2024)
Abstract. Objectives. This study aimed to test the association between of type and number of D'Amico high-risk criteria (DHRCs) with cancer-specific mortality (CSM) in high-risk prostate cancer patients treated with radical prostatectomy. Materials a
Externí odkaz:
https://doaj.org/article/63acf018d2eb4171ba4db35d7818dd58
Autor:
Okyaz Eminaga, Fred Saad, Zhe Tian, Ulrich Wolffgang, Pierre I. Karakiewicz, Véronique Ouellet, Feryel Azzi, Tilmann Spieker, Burkhard M. Helmke, Markus Graefen, Xiaoyi Jiang, Lei Xing, Jorn H. Witt, Dominique Trudel, Sami-Ramzi Leyh-Bannurah
Publikováno v:
npj Imaging, Vol 2, Iss 1, Pp 1-12 (2024)
Abstract Malignancy grading of prostate cancer (PCa) is fundamental for risk stratification, patient counseling, and treatment decision-making. Deep learning has shown potential to improve the expert consensus for tumor grading, which relies on the G
Externí odkaz:
https://doaj.org/article/c4b8543e519440bb95cf3c3b228ab60d
Autor:
Benedikt Hoeh, Marina Kosiba, Mike Wenzel, Nicola Meister, Felix Preisser, Shahrokh F. Shariat, Jan Lukas Hohenhorst, Andreas Becker, Philipp Mandel, Severine Banek, Frederik Roos, Pierre I. Karakiewicz, Felix K.H. Chun, Luis A. Kluth
Publikováno v:
Current Urology, Vol 17, Iss 4, Pp 292-298 (2023)
Abstract. Objectives. To test for differences in overall and recurrence-free survival between laparoscopic and open surgical approaches in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Materials and
Externí odkaz:
https://doaj.org/article/6abe7a9f91234026b86f81cda944bc34
Autor:
Carolin Siech, Mike Wenzel, Carsten Lange, Cristina Cano Garcia, Clara Humke, Zhe Tian, Pierre I. Karakiewicz, Miriam Traumann, Luis A. Kluth, Felix K. H. Chun, Benedikt Hoeh, Philipp Mandel
Publikováno v:
Medicina, Vol 60, Iss 7, p 1119 (2024)
Background: Biochemical recurrence (BCR) represents the rise of prostate-specific antigen (PSA) levels after treatment with curative radical prostatectomy (RP) or radiation for prostate cancer. The objective of the current study was to test for the a
Externí odkaz:
https://doaj.org/article/0544fb20ff014d56a4d93431d5723e53
Autor:
Okyaz Eminaga, Fred Saad, Zhe Tian, Ulrich Wolffgang, Pierre I. Karakiewicz, Véronique Ouellet, Feryel Azzi, Tilmann Spieker, Burkhard M. Helmke, Markus Graefen, Xiaoyi Jiang, Lei Xing, Jorn H. Witt, Dominique Trudel, Sami-Ramzi Leyh-Bannurah
Publikováno v:
npj Imaging, Vol 2, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/6e50e8000ef34e08b3aaca7284d9f850
Autor:
Mattia L. Piccinelli, Stefano Tappero, Cristina Cano Garcia, Francesco Barletta, Reha-Baris Incesu, Simone Morra, Lukas Scheipner, Zhe Tian, Stefano Luzzago, Francesco A. Mistretta, Matteo Ferro, Fred Saad, Shahrokh F. Shariat, Sascha Ahyai, Nicola Longo, Derya Tilki, Alberto Briganti, Felix K.H. Chun, Carlo Terrone, Ottavio de Cobelli, Gennaro Musi, Pierre I. Karakiewicz
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 109-115 (2023)
Background: Guidelines recommend VENUSS and GRANT models for the prediction of cancer control outcomes after nephrectomy for nonmetastatic papillary renal cell carcinoma (pRCC). Objective: To test the ability of VENUSS and GRANT models to predict 5-y
Externí odkaz:
https://doaj.org/article/f675564d985b40d3beecc31ba1c796f2
Autor:
Markus von Deimling, Laura S. Mertens, Bas W.G. van Rhijn, Yair Lotan, Philippe E. Spiess, Siamak Daneshmand, Peter C. Black, Maximilian Pallauf, David D'Andrea, Marco Moschini, Francesco Soria, Francesco Del Giudice, Luca Afferi, Ekaterina Laukhtina, Takafumi Yanagisawa, Tatsushi Kawada, Jeremy Y.-C. Teoh, Mohammad Abufaraj, Guillaume Ploussard, Mathieu Roumiguié, Pierre I. Karakiewicz, Marko Babjuk, Paolo Gontero, Evanguelos Xylinas, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
European Urology Open Science, Vol 51, Iss , Pp 39-46 (2023)
Background: There are currently no guideline recommendations regarding the treatment of cisplatin-ineligible, clinically lymph node–positive (cN+) bladder cancer (BCa). Objective: To investigate the oncological efficacy of gemcitabine/carboplatin i
Externí odkaz:
https://doaj.org/article/ca1ab60ba464424d84a6c7187bdbb8f7
Autor:
Takafumi Yanagisawa, Pawel Rajwa, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Muhammad Majdoub, Marcin Chlosta, Pierre I. Karakiewicz, Axel Heidenreich, Takahiro Kimura, Shahrokh F. Shariat
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2194-2216 (2023)
(1) Background: Local therapy is highly promising in a multimodal approach strategy for patients with low-volume metastatic prostate cancer (mPCa). We aimed to systematically assess and summarize the safety, oncologic, and functional outcomes of cyto
Externí odkaz:
https://doaj.org/article/d8d7f6a3563f45a6b7a29dda6856ac73